{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-090842","form_type":"8-K","ticker":"ADGM","cik":"0002006986","company_name":"Adagio Medical Holdings, Inc.","filed_at":"2024-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.348867+00:00","generated_at":"2026-05-31T08:44:33.705887+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Adagio Medical obtains CE Mark for VT catheter, closes business combination with $35M pro forma cash","bullets":["CE Mark approval and commercial launch of vCLAS catheter for ventricular tachycardia in select European markets.","FDA approved FULCRUM-VT pivotal IDE study for VT cryoablation system; patient enrollment starts September 2024.","Closed business combination with ARYA Sciences Acquisition Corp; shares listed on Nasdaq under ADGM on Aug 1, 2024.","Raised approx. $84.2M from trust, PIPE, and convertible financing; pro forma cash ~$35M after transaction costs."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-090842","json":"https://secwatch.observer/filing/0001104659-24-090842.json","markdown":"https://secwatch.observer/filing/0001104659-24-090842.md","text":"https://secwatch.observer/filing/0001104659-24-090842.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2006986/000110465924090842/0001104659-24-090842-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2006986/000110465924090842/tm2422065d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:44:33.705887+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}